BACKGROUND AND OBJECTIVES: To have better understanding on the pathophysiology of rhinovirus infection, an availability of an ideal experimental model is of utmost importance. We aimed to develop a new study model using the organ culture of turbinate mucosa to overcome the limitations of the conventional study methods. MATERIALS AND METHOD: The inferior turbinate mucosae harvested during the septoturbinoplasty were cultured in air-liquid interface methods, placed on the support of gelfoam soaked in the culture media. Human rhinovirus -16 was applied on the top of the mucosal surface. The success of rhinovirus infection was determined by semi-nested RT-PCR of the mucosal surface fluid taken 48 hours after incubation. Intracellular rhinovirus was visualized by in situ hybridization. Elaboration of cytokine IL-6 and IL-8 into the culture media was quantitated using the ELISA method. RESULTS: PCR product of 292 bp on semi-nested RT-PCR, representing successful rhinovirus infection, was detected in 5 tissues out of 10 mucosal tissues. In the in situ hybridization method, positively stained cells were found in epithelial layer in scattered fashion. In the analysis of cytokine production by continuous exposure to rhinovirus according to the time course, IL-6 and IL-8 secretions in the infected mucosae were significantly greater than in the control mucosa. The increase in the cytokine production was evident from 24 hours after the infection. CONCLUSION: The results of this study indicate that the organ culture of turbinate mucosa could serve as an acceptable in vitro model for studying pathophysiology of rhinovirus infection.
Culture Media ; Enzyme-Linked Immunosorbent Assay ; Gelatin Sponge, Absorbable ; Humans ; In Situ Hybridization ; Interleukin-6 ; Interleukin-8 ; Models, Theoretical ; Mucous Membrane* ; Organ Culture Techniques* ; Polymerase Chain Reaction ; Rhinovirus* ; Turbinates*

The followings are the results for external quality assessment (EQA) in immunoserology for 2003: 1.Evaluation of EQA was done in 2 trials in May and November, about 99% of laboratories participating average 8.2 items. 2.In C-reactive protein (CRP), rheumatoid factor (RF) and anti-streptolysin O (ASO) tests, about 63%, 49% and 44% of the participating laboratories respectively have used quantitative assays. Because the laboratories using quanitiative assays were on the increase annually, commercial control, Liquicheck(TM) Immunology Contol from Bio-Rad Laboratories (Irvine, CA, USA) was used to assure the quality of quantitiavie results in 2003. A few laboratories reproted the outlier results, comparing with the reference ranges presented by the company. 3.Over 92% of participating laboratoreis have used imunoassays including enzyme immunoassay (EIA), microparticle EIA (MEIA), chemiluminescence immunoassay (CIA), immunochromatography assay (ICA) or radioimmunoassay (RIA) for detedting viral antigens or antibodies. Especially for anti-HCV, over 98% of participating laboratoreis have used various kind of imunoassays. Laboratories using ICA increased and about 24% of participating laboratoreis have used ICA for anti-HCV and anti-HIV. However, many laboratories using ICA for detecting anti-HCV reported false negative results, suggesting lower sensitivity of ICA than those of other immunoassays. 4.The criteria of interpretation were considered to be evaluated in Widal test and laboratories using ICA increased in serological tests for syphilis.
Allergy and Immunology ; Antibodies ; Antigens, Viral ; C-Reactive Protein ; Hepatitis B Surface Antigens ; Immunoassay ; Immunochromatography ; Immunoenzyme Techniques ; Korea* ; Luminescence ; Nephelometry and Turbidimetry ; Radioimmunoassay ; Reference Values ; Rheumatoid Factor ; Serologic Tests ; Syphilis

The followings are the results for external quality assessment (EQA) in immunoserology for 2004: 1. Evaluation of EQA was done in 2 trials in May and November, about 99% of laboratories participating average 8.4 items. EQA for anti-HBc test was newly started in 2004. 2. Commercial control, MASR Immunology Control from Medical Analysis Systems (Camarillo, CA, USA) was used to assure the quality of quantitative results of C-reactive protein (CRP), rheumatoid factor (RF) and anti-streptolysin O (ASO) tests in 2004. All the specimens for Immunoserology in EQA were delivered refrigerated for the first time, being received within 48 hours after sending. 3. EQA for detection of HBsAg mutants was tried for the first time, using the recombinant HBsAg mutant (Gly/Arg 145) kindly provided by Abbott Laboratories, USA. 4. The laboratories using immunochromatography assay (ICA) were increased, however, many laboratories using ICA reported falsely negative for the positive specimens. The sensitivity of ICA test kits as well as various factors influencing the ICA results should be evaluated. 5. Standardization of methods including calibrators for quantitative results should be required for the harmonization of results.
Allergy and Immunology ; C-Reactive Protein ; Hepatitis B Surface Antigens ; Immunochromatography ; Korea* ; Nephelometry and Turbidimetry ; Rheumatoid Factor

OBJECTIVE: To evaluate the feasibility of five-dimensional Long Bone (5D LB), a new technique that automatically archives, reconstructs images, and measures lengths of fetal long bones, to assess whether the direction of volume sweep influences fetal long bone measurements in three-dimensional (3D) ultrasound and 5D LB, and to compare measurements of fetal long bone lengths obtained with 5D LB and those obtained with conventional two-dimensional (2D) and manual 3D techniques. METHODS: This prospective study included 39 singleton pregnancies at 26+0 to 32+0 weeks of gestation. Multiple pregnancies, fetuses with multiple congenital anomalies, and mothers with underlying medical diseases were excluded. Fetal long bones of the lower extremities-the femur, tibia, and fibula were measured by 2D and 3D ultrasound, and 5D LB, by an expert and non-expert examiner. First, we analyzed the 3D ultrasound and 5D LB data according to 2 different sweeping angles. We analyzed intra- and inter-observer variability and agreement between ultrasound techniques. Paired t-test, interclass correlation coefficient, and Bland-Altman plot and Passing-Bablok regression were used for statistical analysis. RESULTS: There was no statistical difference between long bone measurements analyzed according to 2 different volume-sweeping angles by 3D ultrasound and 5D LB. Intra- and inter-observer variability were not significantly different among all 3 ultrasound techniques. Comparing 2D ultrasound and 5D LB, the interclass correlation coefficient for femur, tibia, and fibula was 0.91, 0.92, and 0.89, respectively. CONCLUSION: 5D LB is reproducible and comparable with conventional 2D and 3D ultrasound techniques for fetal long bone measurement.
Female ; Femur ; Fetus ; Fibula ; Humans ; Mothers ; Observer Variation ; Pregnancy ; Pregnancy, Multiple ; Prospective Studies ; Tibia ; Ultrasonography

The followings are the results for external quality assessment (EQA) in immunoserology for 2007: 1. Evaluation of EQA was done in 2 trials in May and December, about 99% of laboratories participating average 7.8 items. The results were collected via internet for the first time and 96~98% of laboratories have sent their results via internet. 2. All the specimens for Immunoserology in EQA were delivered refrigerated, being received within 48 hours after sending. 3. Commercial controls, MASR Immunology Control from Medical Analysis Systems (Camarillo, CA, USA) were used to assure the quality of quantitative results of C-reactive protein (CRP), rheumatoid factor (RF) and anti- streptolysin O (ASO) tests, and the RF results of MASR Immunology Control were variable depending on the reagents used. 4. The laboratories using immunochromatography assay (ICA) were increased, however, many laboratories using ICA reported falsely negative for the positive specimens. The sensitivity of ICA test kits as well as various factors influencing the ICA results should be evaluated. 5. The HBsAg results of the ACCURUN 1R Multi-Marker Positive Control (Boston Biomedica Inc. USA) were falsely reported as negative in some laboratories using arbitrarily determined cutoff. 6. Standardization of methods including calibrators for quantitative results should be required for the harmonization of results.
Bacterial Proteins ; C-Reactive Protein ; Hepatitis B Surface Antigens ; Immunochromatography ; Indicators and Reagents ; Internet ; Korea ; Nephelometry and Turbidimetry ; Rheumatoid Factor ; Streptolysins

The followings are the results for external quality assessment (EQA) in immunoserology for 2007: 1. Evaluation of EQA was done in 2 trials in May and December, about 99% of laboratories participating average 7.8 items. The results were collected via internet for the first time and 96~98% of laboratories have sent their results via internet. 2. All the specimens for Immunoserology in EQA were delivered refrigerated, being received within 48 hours after sending. 3. Commercial controls, MASR Immunology Control from Medical Analysis Systems (Camarillo, CA, USA) were used to assure the quality of quantitative results of C-reactive protein (CRP), rheumatoid factor (RF) and anti- streptolysin O (ASO) tests, and the RF results of MASR Immunology Control were variable depending on the reagents used. 4. The laboratories using immunochromatography assay (ICA) were increased, however, many laboratories using ICA reported falsely negative for the positive specimens. The sensitivity of ICA test kits as well as various factors influencing the ICA results should be evaluated. 5. The HBsAg results of the ACCURUN 1R Multi-Marker Positive Control (Boston Biomedica Inc. USA) were falsely reported as negative in some laboratories using arbitrarily determined cutoff. 6. Standardization of methods including calibrators for quantitative results should be required for the harmonization of results.
Bacterial Proteins ; C-Reactive Protein ; Hepatitis B Surface Antigens ; Immunochromatography ; Indicators and Reagents ; Internet ; Korea ; Nephelometry and Turbidimetry ; Rheumatoid Factor ; Streptolysins

The followings are the results for external quality assessment (EQA) in immunoserology for 2008:1.Evaluation of EQA was done in 2 trials in May and November, about 99% of laboratories participating average 7.7 items. The results were collected via internet and about 99% of laboratories have sent their results via internet. 2.Control materials used in the External Proficiecny Testing were pooled sera including Commercial controls, MAS(R) Immunology Control from Medical Analysis Systems (Camarillo, CA, USA), which were delivered refrigerated for stability of control materials, being received within 48 hours after sending. 3.Latex agglutination tests for rheumatoid factor (RF) showed frequently false positive or false negative results especially in Commercial controls, possibly due to matrix effect.4.False negative and positive results were frequently found in the laboratories using immunochromatography assay (ICA) for anti-HCV and anti-HIV. More careful quality control should be required for ICA tests. 5.New tests measuring non-treponemal and trponemal antibody such as turbidoimmunoassay (TIA) and chemiluminescence immunoassay (CLIA) were introduced.6.Standardization of instruments and reagents including calibrators for quantitative results should be required for the harmonization of results.
Agglutination Tests ; Hepatitis B Surface Antigens ; Immunoassay ; Immunochromatography ; Indicators and Reagents ; Internet ; Korea ; Luminescence ; Nephelometry and Turbidimetry ; Quality Control ; Rheumatoid Factor

The followings are the results for external quality assessment (EQA) in immunoserology for 2009: Evaluation of EQA was done in 2 trials in April and November, about 99% of laboratories participating average 7.4 items. The results were collected via internet and about 98% of laboratories have sent their results via internet. Control materials used in EQA were pooled sera including commercial controls, MASR Immunology Control from Medical Analysis Systems (Camarillo, CA, USA), which were delivered refrigerated for stability of control materials, being received within 48 hours after sending. Latex agglutination tests for rheumatoid factor (RF) showed frequently false positive or false negative results especially in commercial controls, possibly due to matrix effect. False negative and positive results were frequently found in the laboratories using immunochromatography assay (ICA) for anti-HCV and anti-HIV. More careful quality control should be required for ICA tests. New tests measuring non-treponemal and trponemal antibody such as turbidoimmunoassay (TIA) and chemiluminescence immunoassay (CLIA) were introduced. Standardization of instruments and reagents including calibrators for quantitative results should be required for the harmonization of results.
Hepatitis B Surface Antigens ; Immunoassay ; Immunochromatography ; Indicators and Reagents ; Internet ; Korea ; Latex Fixation Tests ; Luminescence ; Nephelometry and Turbidimetry ; Quality Control ; Rheumatoid Factor

The followings are the results for external quality assessment (EQA) in immunoserology for 2005: 1.Evaluation of EQA was done in 2 trials in May and December, about 99% of laboratories participating average 8.4 items. The results were collected via internet for the first time and 66~78% of laboratories have sent their results via internet. 2.Commercial controls, MASR Immunology Control from Medical Analysis Systems (Camarillo, CA, USA) and Immunology Control (Immuno-Q-sera I, SEIKEN, Japan) were used to assure the quality of quantitative results of C-reactive protein (CRP), rheumatoid factor (RF) and anti-streptolysin O (ASO) tests. All the specimens for Immunoserology in EQA were delivered refrigerated, being received within 48 hours after sending. 3.Commercial control for serologic tests for syphilis, Syphilis Control (Mediace RPR con, Sekisui, Japan) was newly introduced in 2005. 4.The laboratories using immunochromatography assay (ICA) were increased, however, many laboratories using ICA reported falsely negative for the positive specimens. The sensitivity of ICA test kits as well as various factors influencing the ICA results should be evaluated. 5.Standardization of methods including calibrators for quantitative results should be required for the harmonization of results.
Allergy and Immunology ; C-Reactive Protein ; Hepatitis B Surface Antigens ; Immunochromatography ; Internet ; Korea* ; Nephelometry and Turbidimetry ; Rheumatoid Factor ; Serologic Tests ; Syphilis